Former Queensland Premier Peter Beattie has urged Australian superannuation funds to consider investing in innovation via appropriate models.
Addressing the Conference of Major Super Funds in Brisbane, Beattie outlined the success enjoyed by the Medical Research Commercialisation Fund (MRCF) and the involvement of two superannuation funds in the underlying model.
He said he believed the MRCF model provided a model that was unique and worth following.
Beattie said this was particularly the case when Australia spent more than $1 billion on research and development, but a fraction of that on commercialisation.
He said he believed Australia should develop a pool of funds for commercialising its research ideas and that superannuation funds should support the establishment of that pool of funds.
Jim Chalmers has defended changes to the Future Fund’s mandate, referring to himself as a “big supporter” of the sovereign wealth fund, amid fierce opposition from the Coalition, which has pledged to reverse any changes if it wins next year’s election.
In a new review of the country’s largest fund, a research house says it’s well placed to deliver attractive returns despite challenges.
Chant West analysis suggests super could be well placed to deliver a double-digit result by the end of the calendar year.
Specific valuation decisions made by the $88 billion fund at the beginning of the pandemic were “not adequate for the deteriorating market conditions”, according to the prudential regulator.